Posts tagged as: PSID stock chart back to homepage

PositiveID Stock Chart Analysis Video PositiveID Stock Chart Analysis Video(0)

The PositiveID (OTCBB: PSID) stock chart made a new 52-week low yesterday before buying pressure pulled the stock price up to close the day with a hammer/doji candle. A possible reversal candle, the chart is holding support firmly at 3 cents with resistance not coming into play until 4 cents. A long-term positive divergence between the MACD and the PPS has the chart on radar for an overall trend shift. Read More

Stay Informed

Receive the OTCS Newsletter *


* required

Dana-Farber to Host Cellceutix Trials

Cellceutix Corporation (CTIX)
Cellceutix Corporation has filed its Investigational New Drug application with the FDA. Dana-Farber and Beth Israel Deaconess Medical Center will be hosting the clinical trials for Kevetrin, Cellceutix's novel cancer drug. Read more news and get a stock quote.

Diabetes Rate Growing Exponentially

According to the International Diabetes Federation, more than 500 million people will be diagnosed with diabetes in the next two decades, a more than 50 percent increase from today. Technologies are available presently to help manage the frequency, complications and costs associated with diabetes. Read the complete article to learn more.

Contacts and information

Have an opinion or news that you want to share?

Social networks

Most popular categories

© 2011 Viper Enterprises, LLC. All rights reserved.